Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Yingcheng Wei"'
Autor:
Wenliang Tan, Kelin Zhang, Xinming Chen, Lei Yang, Sicong Zhu, Yingcheng Wei, Zhiqin Xie, Yajin Chen, Changzhen Shang
Publikováno v:
Journal of Advanced Research, Vol 44, Iss , Pp 173-183 (2023)
Introduction: Lenvatinib has recently become available as the first-line therapy for advanced hepatocellular carcinoma (HCC), but its molecular mechanism in HCC remains largely unknown. Objectives: The current study aims to identify the molecular mec
Externí odkaz:
https://doaj.org/article/e3cf10af10d14fd3a4630edb349b0f00
Autor:
Lei Yang, Wenliang Tan, Yingcheng Wei, Zhiqin Xie, Wenxin Li, Xiaowu Ma, Qingbin Wang, Huilong Li, Ziyu Zhang, Changzhen Shang, Yajin Chen
Publikováno v:
Cell Death and Disease, Vol 13, Iss 5, Pp 1-11 (2022)
Abstract Circular RNAs have been reported to play essential roles in the tumorigenesis and progression of various cancers. However, the biological processes and mechanisms involved in hepatocellular carcinoma (HCC) remain unclear. Initial RNA-sequenc
Externí odkaz:
https://doaj.org/article/10bedf23e25e486c8c9368b987a3b047
miR-126-3p contributes to sorafenib resistance in hepatocellular carcinoma via downregulating SPRED1
Autor:
Xianqing Chen, Wenxin Li, Wenliang Tan, Changzhen Shang, Yajin Chen, Zhirong Lin, Liyun Huo, Yingcheng Wei, Sicong Zhu
Publikováno v:
Ann Transl Med
Background Sorafenib can prolong the survival of patients with advanced hepatocellular carcinoma (HCC). However, drug resistance remains the main obstacle to improving its efficiency. This study aimed to explore the likely molecular mechanism of sora
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5208d441ce111ea8a5f13ba20596a9cd
https://europepmc.org/articles/PMC7859776/
https://europepmc.org/articles/PMC7859776/
